Arteris (NASDAQ:AIP) Stock: Insider Paul Alpern Sells 6,003 Shares

Posted by Geri Gentry on Oct 6th, 2026

Arteris, Inc. (NASDAQ:AIP – Get Free Report) VP Paul Alpern sold 6,003 shares of the firm’s stock in a transaction on Monday, October 5th. The shares were sold at an average price of $24.24, for a total value of $145,512.72. Following the transaction, the vice president owned 61,082 shares of the company’s stock, valued at $1,480,627.68. The trade was a 8.95% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Arteris Stock Up 0.7%

Shares of AIP traded up $0.16 during trading hours on Tuesday, hitting $24.13. The company had a trading volume of 476,272 shares, compared to its average volume of 728,847. The firm has a fifty day moving average price of $24.73 and a 200-day moving average price of $28.61. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.57 and a current ratio of 1.57. The stock has a market capitalization of $1.19 billion, a price-to-earnings ratio of -27.74 and a beta of 1.90. Arteris, Inc. has a 52-week low of $12.06 and a 52-week high of $50.26.

Arteris (NASDAQ:AIP – Get Free Report) last announced its quarterly earnings data on Thursday, August 6th. The company reported ($0.10) EPS for the quarter, missing the consensus estimate of ($0.04) by ($0.06). The firm had revenue of $24.13 million for the quarter, compared to analysts’ expectations of $23.48 million. Arteris had a negative net margin of 46.70% and a negative return on equity of 295.96%. On average, equities research analysts forecast that Arteris, Inc. will post -0.68 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on AIP shares. Weiss Ratings upgraded shares of Arteris from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday, August 21st. Roth Capital started coverage on Arteris in a research report on Tuesday, August 4th. They issued a “buy” rating and a $40.00 price objective on the stock. Craig Hallum assumed coverage on Arteris in a research report on Monday, September 21st. They issued a “buy” rating and a $30.00 price objective on the stock. Jefferies Financial Group upgraded Arteris from a “hold” rating to a “buy” rating and increased their target price for the company from $35.00 to $50.00 in a research note on Friday, August 7th. Finally, Oppenheimer assumed coverage on Arteris in a report on Thursday, July 16th. They issued an “outperform” rating and a $40.00 target price for the company. Six investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Arteris presently has an average rating of “Moderate Buy” and an average target price of $39.43.

View Our Latest Analysis on Arteris

Institutional Investors Weigh In On Arteris

A number of hedge funds have recently added to or reduced their stakes in the stock. Mitsubishi UFJ Asset Management Co. Ltd. bought a new position in shares of Arteris during the 2nd quarter valued at $53,000. Versant Capital Management Inc grew its holdings in Arteris by 33.7% during the second quarter. Versant Capital Management Inc now owns 1,150 shares of the company’s stock valued at $56,000 after purchasing an additional 290 shares during the period. Allworth Financial LP bought a new position in shares of Arteris during the 2nd quarter valued at approximately $87,000. State of Wyoming purchased a new stake in shares of Arteris in the second quarter worth $165,000. Finally, Royal Bank of Canada increased its stake in Arteris by 366.7% in the 1st quarter. Royal Bank of Canada now owns 4,023 shares of the company’s stock worth $66,000 after buying an additional 3,161 shares in the last quarter. 64.36% of the stock is currently owned by hedge funds and other institutional investors.

Key Headlines Impacting Arteris

Here are the key news stories impacting Arteris this week:

Positive Sentiment: Arteris won an additional $3.3 million through the Trusted and Assured Microelectronics program to expand its third-party semiconductor IP security-assurance efforts. The company is collaborating with BAE Systems and SiFive, potentially strengthening its position in defense-related and trusted-chip supply chains. Arteris funding announcement
Neutral Sentiment: CEO K. Charles Janac and Vice President Paul Alpern sold shares, but the filings state the transactions were made to cover tax withholding obligations related to vested equity awards. Because these were tax-related sales rather than clearly discretionary trades, they provide a limited signal about management’s outlook. SEC filing for executive share sales
Negative Sentiment: Major shareholder Bayview Legacy LLC sold 100,000 shares for approximately $2.38 million, reducing its ownership by 1.22%. The filing did not cite tax withholding as the reason, so the sale could create modest supply pressure and raise concerns about near-term shareholder confidence. SEC filing for Bayview Legacy share sale

Arteris Company Profile

(Get Free Report)

Arteris, Inc is a semiconductor intellectual property (IP) company that develops technologies used in the design of system-on-chip (SoC) devices. Its products help semiconductor and electronics companies connect, manage and protect the various processing, memory and other functional components integrated into complex chips.

The company’s portfolio includes network-on-chip (NoC) interconnect IP, which supports communication among different elements within an SoC, as well as cache-coherent interconnect, system IP and related design technologies.